Search Results

You are looking at 101 - 110 of 232 items for :

Clear All
Full access

Rodger J. Winn

, multidisciplinary management and outcome of treatment for soft tissue sarcomas . Ann Oncol 2004 ; 15 : 307 – 315 . 17 National Health and Medical Research Council . Psychosocial clinical practice guidelines . Information, support and counseling for

Full access

Suneel D. Kamath, Sheetal M. Kircher and Al B. Benson III

types with only 1 NPO supporting them were neuroendocrine, nonmelanoma skin, liver and bile duct, cervical, and endometrial cancers; myelodysplastic syndromes (MDS); and sarcoma. Cancers with the lowest total annual revenue were sarcoma ($5.1 million; 0

Full access

Harold J. Burstein

information as anyone, and maybe more. David Rakoff, writing in The New York Times Sunday Magazine ( http://www.nytimes.com/2011/04/17/magazine/mag-17lives-t.html?ref=magazine ), described his experiences as a sarcoma patient. He entitled his essay “The

Full access

Camila Santos Rodrigues and Gabriela Villaça Chaves

.2 ± 9.5 years. Low SMI was associated with sarcoma histologic type and a coexistent diagnosis of diabetes mellitus and systemic arterial hypertension ( Table 2 ). Table 1. Skeletal Muscle Parameters and Fat Mass Distribution The highest

Full access

Christian J. d MS, MPH Armbrecht Eric S. b PhD Buckhold Fred R. a MD Burroughs Thomas E. b PhD 2 2018 16 16 2 2 136 136 143 143 10.6004/jnccn.2017.7037 jnccn_16_2_007 The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of

Full access

cancer, breast cancer, diffuse large B-cell lymphoma, and Kaposi sarcoma. IBM also helped transform the ACS ChemoSafe Facility Assessment Tool—from an Excel-based document to an interactive, easy-to-use mobile application—to scale the program’s goal of

Full access

Myelogenous Leukemia; Lung Cancer Screening; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; and Soft Tissue Sarcoma. NCCN Quick Guide sheets are currently available for Esophageal Cancer, Prostate Cancer, Stage IV Breast Cancer, Lung Cancer

Full access

Peter F. Coccia, Jessica Altman, Smita Bhatia, Scott C. Borinstein, Joseph Flynn, Suzanne George, Robert Goldsby, Robert Hayashi, Mary S. Huang, Rebecca H. Johnson, Lynda Kwon Beaupin, Michael P. Link, Kevin C. Oeffinger, Kathleen M. Orr, Alberto S. Pappo, Damon Reed, Holly L. Spraker, Deborah A. Thomas, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Bradley J. Zebrack, Hema Sundar and Dorothy A. Shead

homicide, suicide, or unintentional injury. 5 , 9 Lymphomas, melanoma, testicular cancer, female genital tract malignancies, thyroid cancer, bone and soft tissue sarcomas, leukemias, central nervous system (CNS) cancers, breast cancer, and nongonadal germ

Full access

Peter F. Coccia, Alberto S. Pappo, Lynda Beaupin, Virginia F. Borges, Scott C. Borinstein, Rashmi Chugh, Shira Dinner, Jeanelle Folbrecht, A. Lindsay Frazier, Robert Goldsby, Alexandra Gubin, Robert Hayashi, Mary S. Huang, Michael P. Link, John A. Livingston, Yousif Matloub, Frederick Millard, Kevin C. Oeffinger, Diane Puccetti, Damon Reed, Steven Robinson, Abby R. Rosenberg, Tara Sanft, Holly L. Spraker-Perlman, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Nicholas Yeager, Lisa A. Gurski and Dorothy A. Shead

), non-Hodgkin's lymphoma (NHL), astrocytomas, Ewing sarcoma, rhabdomyosarcoma, or osteosarcoma. 18 Additionally, for Ewing sarcoma, outcomes are worse for patients ≥18 years of age compared with patients <18 years. 19 – 21 Conversely, 5-year relative

Full access

Lucas Vieira dos Santos, João Paulo Lima, Kathia Cristina Abdalla, Arinilda Campos Bragagnoli, Florinda Almeida Santos, Alexandre dos Anjos Jácome and Fabiano Elias Porto

. Lancet 2004 ; 364 : 1127 – 1134 . 6. Verweij J van Oosterom A Blay JY . Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are